CardioDx Press Release - CardioDx Honored as One of FierceMedicalDevices’ Fierce 15 Most Promising Private Companies
PALO ALTO, Calif. – Oct. 2, 2012 – CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company has been named one of FierceMedicalDevices’ Fierce 15 most promising privately held medical device and diagnostics companies in the world. FierceMedicalDevices editors chose this year's winners based on their top management teams, notable financial backing, promising technologies and market opportunities. The award was presented today at an event that took place during AdvaMed 2012: The MedTech Conference in Boston, Mass.
© 2023 Pappas Capital, LLC. ALL RIGHTS RESERVED.